Variant #0000817937 (NC_000001.10:g.171178090=, NM_001460.3:c.1414= (FMO2))
| Chromosome |
1 |
| Allele |
Unknown |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Not classified |
| Classification method |
- |
| Clinical classification |
association |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.171178090= |
| DNA change (hg38) |
g.171208951C>T |
| Published as |
- |
| ISCN |
- |
| DB-ID |
FMO2_000002 |
| Variant remarks |
Ancestral allele (C) is associated with reduced risk for active TB. Major allele (T) is associated with a risk of pulmonary toxicity by inducing the adverse metabolism of particular anti-TB drugs. |
| Reference |
PubMed: Mekonnen 2017, Journal: Mekonnen 2017 |
| ClinVar ID |
- |
| dbSNP ID |
rs6661174 |
| Origin |
Germline |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
0.01073 View details |
| Owner |
Ephrem Mekonnen |
| Database submission license |
No license selected |
| Created by |
Ephrem Mekonnen |
| Date created |
2021-10-31 13:52:44 +01:00 (CET) |
| Date last edited |
2023-01-31 10:55:14 +01:00 (CET) |

Variant on transcripts
Screenings
|